Stay updated on Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page's revision tag has been updated to v3.6.2, indicating a newer version of the page. The update does not change study details or user-facing information.
    Difference
    0.0%
    Check dated 2026-06-26T23:54:18.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The study record now shows that recruitment is closed and no longer looking for participants. New sections for How to Read a Study Record, Common Questions, and How to Join a Study were added, and the Intervention/Treatment heading was reformatted.
    Difference
    0.4%
    Check dated 2026-06-12T14:18:12.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.5 instead of Revision: v3.5.4. This reflects a minor site revision rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-05T10:37:15.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, indicating a newer version of the page content. The change does not affect the study details displayed.
    Difference
    0.0%
    Check dated 2026-05-14T23:26:42.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision updated to v3.5.3, replacing the previous v3.5.2. This represents a minor documentation/versioning update and does not change study details or eligibility content.
    Difference
    0.0%
    Check dated 2026-04-30T17:27:24.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.2; the v3.5.0 label was removed. This is a routine site maintenance update and does not affect the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-04-16T10:22:20.000Z thumbnail image

Stay in the know with updates to Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib-Nivolumab Combo in Hematologic Malignancies Clinical Trial page.